In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy.
about
Tau-mediated synaptic damage in Alzheimer's diseaseInvestigating GluCEST and its specificity for pH mapping at low temperatures.Interrogating Metabolism in Brain Cancer.CEST imaging of fast exchanging amine pools with corrections for competing effects at 9.4 T.Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy.Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases.Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.Increased CEST specificity for amide and fast-exchanging amine protons using exchange-dependent relaxation rate.Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.In vivo GluCEST MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of Parkinson's disease.Maturational decrease of glutamate in the human cerebral cortex from childhood to young adulthood: a 1H-MR spectroscopy study.Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease.Imaging of Glial Activation in Alzheimer's Disease
P2860
Q28831067-25596DB1-6DF9-4C96-A50E-08A8DBC2F7F2Q30998260-5D037E94-4506-4ACF-9A43-9DB43D62D3BEQ31136705-085202DC-45E3-4CF8-B0C7-F41F9779AB7DQ31172515-F39AB3A1-2DB0-4E03-9F5F-F8E976D4F2A8Q33743741-BE0B0068-FDE1-42E7-9202-B08D830E15BCQ34794030-62F401A5-B10E-426C-84E4-FB1BC50A9CCFQ36354566-0C5AA97B-36EC-4332-A7A9-871ED9216616Q36455556-862F46EB-EFC3-42F1-8D50-6A86746614A4Q38918493-44F14585-DF71-4D83-98F3-F83D55AFF173Q40415700-B105DE3A-D20B-4CD4-93DB-676AE94B5FD1Q42716494-A830162C-035D-4B30-9539-6369BDC8DEFEQ47295877-BDDE1AD9-D3AB-41F8-8E70-4B622AC4FEACQ47350915-1C5456C7-0944-4867-A35C-80446076BF34Q48343342-29CB9F71-EDC7-4CA1-A57B-C2C414E38D3FQ50025519-2114A947-6BA6-4716-984A-4B5E11DA6171Q50742969-FFAC685A-F2C2-4D4E-90C3-EA425E2E3850Q55430546-C45EB88C-0C83-4B53-AD27-206417ADCEBBQ58797155-ED9F75BC-2549-4036-BA36-36CBC0D556D3
P2860
In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@ast
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@en
type
label
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@ast
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@en
prefLabel
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@ast
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@en
P2093
P2860
P1433
P1476
In vivo measurement of glutama ...... in a mouse model of tauopathy.
@en
P2093
Arijitt Borthakur
Catherine DeBrosse
Hari Hariharan
John A Detre
Michiyo Iba
Mohammed Haris
Rachelle Crescenzi
Ravi Prakash Reddy Nanga
Ravinder Reddy
Sanjana Reddy
P2860
P304
P356
10.1016/J.NEUROIMAGE.2014.06.067
P407
P577
2014-07-05T00:00:00Z